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Background: Despite the widespread use of external ventricular drainage, revision rates, and associated complications
are reported between 10 and 40%. Current available image-guided techniques using stereotaxy, endoscopy, or
ultrasound for catheter placements remain time-consuming techniques. Recently, a smartphone-assisted guide
with high precision has been described. The development of an easy-to-use, portable, image-guided system could
reduce the need for multiple passes and improve the rate of accurate catheter placement. This study aims to
prospectively compare in a randomized controlled manner the accuracy of the freehand pass technique versus
an easy-to-use, portable, adjustable guiding device for ventriculostomy catheter placement.
Methods/Design: This is a single center, prospective, randomized trial with a blinded endpoint (ventricular
catheter tip location) assessment. Adult patients with the indication for ventriculostomy, as proven by computed
tomography (CT), will be randomly assigned to the treatment group or the control group. For patients in the
treatment group, ventriculostomy will be performed using an adjustable guiding device and DICOM (Digital Imaging
and Communications in Medicine) image-reading software assistance (for example, using a mini-tablet) based on
preoperative CT imaging.
Patients in the control group will receive standard freehand ventriculostomy using anatomical landmarks. The catheter
may be placed for external drainage or internal (ventriculoperitoneal) shunting in both groups. The primary outcome
measure is the rate of correct placements of the ventricular catheter, defined as a score of 1 to 3 on grading system for
catheter tip location on a postoperative CT scan. Participants will be followed for the duration of hospital stay, an
expected average of two weeks. The primary outcome will be determined by one of the authors blinded to the
treatment allocation. We aim to include 236 patients in three years. Secondary outcome measures include: frequency
of placements required, frequency of completed placements within the ventricle of the perforated part of the catheter
tip, frequency of very early and early shunt failures (revision of the ventricular drainage within 24 hours and within the
hospital stay), frequency and percentage of complications (procedure-related and nonsurgical) at discharge.
Discussion: This is the study design of a single center, prospective, randomized controlled trial to investigate whether
guided ventriculostomy is superior to the standard freehand technique. One strength of this study is the prospective,
randomized, interventional type of study testing a new easy-to-handle guided versus freehand ventricular catheter
placement. A second strength of this study is that the power calculation is based on catheter accuracy using an
available grading system for catheter tip location, and is calculated with the use of recent study results of our own
population, supported by data from prominent studies.
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Ventriculostomy is a common procedure in neurosurgery
and accurate placement of the ventricular catheter is one
of the most important variables in the longevity of shunt
survival [1,2]. Despite this large volume of patients and
technological advances, failure rates due to proximal cath-
eter obstruction with the freehand technique remain high
(12%, 32%,36%, 38%, and 45% in studies [3-7], respectively.
Optimal placement in the ipsilateral anterior horn of the
lateral ventricle just anterior to the foramen of Monro de-
pends on accurate placement of the catheter tip in the
ventricle, away from the choroid plexus and injured epen-
dyma [8], and on proper insertion trajectory and catheter
length [9]. In a retrospective study in 90 patients using
surface anatomical landmarks alone, only 56% of the cath-
eter tips were in the ipsilateral lateral ventricle, 7% were in
the contralateral lateral ventricle, 8% were in the third
ventricle, 6% were within the interhemispheric fissure, and
22% were within extraventricular spaces [10].
The high rate of malplacements led to a search for im-
proved methods that might result in significant patient
benefits. In the last 25 years, techniques using a guide
[11], calculating optimal catheter lengths combining com-
puted tomography (CT) [12], and stereotactic coordinate-
guided freehand methods based on ventricular landmarks
[9,13] have been developed. This was followed by the
more sophisticated methods of the ultrasound transducer
[14-16], neuronavigation, and endoscopic guidance [17].
A very recent study comparing the accuracy of ventricu-
lar catheter placement using the freehand technique,
ultrasonic guidance, and stereotactic neuronavigation
identified the use of the freehand technique as the only
risk factor for inaccurate placement [7]. Current available
image-guided techniques for catheter placements can be
time consuming [14,18], expensive, and may need a larger
burr hole [19]. The development of an easy-to-use, port-
able, image-guided system could reduce the need for mul-
tiple passes and improve the rate of accurate catheter
placement [16]. Recently, a smartphone-assisted guide
was tested in 35 patients with no ventricular catheter fail-
ure occurring during the follow-up period [20].
As there is a need to improve current practices in the
placement of ventricular catheters, this study aims to
compare prospectively and in a randomized controlled
manner the accuracy of the freehand pass technique ver-
sus a portable adjustable guiding device for ventriculost-
omy catheter placement.
Methods/Design
This is a single center, prospective, randomized trial with
a blinded endpoint (ventricular catheter tip location) as-
sessment. Adult patients with the indication for ventricu-
lostomy, as proven by CT, will be randomly assigned to
the treatment group or the control group. For patients inthe treatment group, a ventriculostomy will be per-
formed using an adjustable guiding device and DICOM
(Digital Imaging and Communications in Medicine) image-
reading software assistance (for example, using a mini-
tablet) based on preoperative CT imaging.Design and setting
The guided versus freehand ventriculostomy (VENTRI-
GUIDE) study will be performed as a -two-arm, single
center, randomized controlled trial to compare an inter-
vention group using a guided placement of a ventricular
catheter to a control group receiving standard (freehand)
ventriculostomy with a blinded endpoint (catheter tip lo-
cation) assessment (Figure 1).
The present study is in compliance with the Helsinki
Declaration. The protocol of this study was approved by
the Ethics Committee on Human Research of the Medical
Faculty of the University of Geneva, Switzerland (refer-
ence number: CER 13–175). At the planned start of the
study (1 February 2014), the study center will start
randomization.
Adults with indication for a ventricular drainage are
eligible for trial participation and are recruited for this
study. The choice of the method of the respective opera-
tive procedure is via randomization. All other surgical
and medical treatment is performed according to local
guidelines and standard operating procedures.Subject inclusion criteria
The inclusion criteria for this study are patients aged 18
years or older with an indication for a ventricular drain-
age (such as hydrocephalus, slit ventricles, or pseudotu-
mor cerebri).Subject exclusion criteria
Patients who meet any of the following criteria will be ex-
cluded from the study: pregnancy, concurrent participa-
tion in another interventional trial (participation in an
observational trial is not an exclusion criteria), or if a
frontal burr hole is not available.Randomization
The randomization process will start as soon as possible
after consent to the study has been obtained. Any patient
meeting the inclusion criteria and not violating the exclu-
sion criteria may participate in the VENTRI-GUIDE study
and be randomized to either a guided or freehand ventri-
culostomy. Online randomization will be performed by
the treating physician in the study center using permuted
blocks, to ensure an equal number of patients in both
study arms.
Figure 1 Study design.
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The study is conducted in the neurosurgical department
of a Swiss single center university hospital in adult pa-
tients with an indication for a ventricular drainage (such
as hydrocephalus, slit ventricles, or pseudotumor cerebri).
Data management and monitoring will be performed by
the Geneva study center and statistical analysis by one of
the authors (NS).
For guidance, an easy-to-handle instrument, assisted
by DICOM image-reading software (for example, mini-
I-pad™ application software; Apple™ Inc(Apple Inc.,
Cupertino, California, United States ), is used in order to
achieve precise placement of ventricular catheters on an
every-case basis. The catheter may be placed for external
drainage or internal (ventriculoperitoneal) shunting.
For patients in the guided group, catheter placement is
performed in the operating theatre during anesthesia
under routine sterile conditions and antibiotic prophy-
laxis. The smartphone-assisted technique used for guided
placing of a ventricular catheter through a burr hole
has been previously described in detail [20]. The onlydifference in this study is the use of an easy-to-use port-
able DICOM image-reading software assistance (for ex-
ample, using a mini-tablet) available for all neurosurgeons
instead of a smartphone. In brief, the patient is positioned
and draped in typical sterile fashion for a ventriculostomy
(if necessary, the operation field is enlarged for shunt
placement. Then, a frontal burr hole is made using a
standard adult perforator.
The guiding instrument consists of a base with three
pins to be rigidly placed on the bone surface over the burr
hole. A semicircular guide rod (Aesculap AG, Tuttlingen,
Germany is mounted to the base in which an angle scale
is engraved. Within the guide rod, a tube can be individu-
ally adjusted in one orientation at different angulations
with a range from −60° to 60°. Different tubes are designed
with inner diameters of 2, 2.5, and 3 mm in order to guide
catheters at different sizes. At the respective angle adjust-
ment, the tube is fixed to the guide rod by a mounting
screw. The base is opened at one side to enable the view
or insertion of any instrument towards the lower opening
of the tube. The guiding tool is positioned parallel to the




Location of catheter tip
1 Optimal/adequate Ipsilateral frontal horn, including tip of third
ventricle: 1a, no contact with ventricle wall;
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the instrument. Thereby, a rectangular insertion towards
the sagittal convexity and an individual insertion angle to-
wards the coronal tangent at the entry point can be estab-
lished via the tube.
After opening the dura, once the appropriate trajectory
is chosen, a ventricular catheter is inserted according to
the pre-calculated insertion angle (for a detailed de-
scription see Thomale et al. [20]). After receiving tactile
feedback from entering the ventricle, the stylet is remo-
vedCerebrospinal fluid (CSF) drainage ensures that the
ventricular catheter is correctly in place. Catheters
deemed to be suboptimally placed are repositioned when
necessary. We rely on length markings on the ventricular
catheter and, when possible, flow through the distal cath-
eter to ensure the catheter has not been moved after fix-
ation to the skin and is continuing to provide a conduit
for CSF. The remainder of any following shunt procedure
or connection to an Ommaya reservoir will be performed
using standard techniques.
The classical freehand technique uses anatomical land-
marks and the catheter is placed in the anterior horn of
the lateral ventricle through a burr hole just anterior to
the coronal suture in the mid-pupillary line (at the level
of Kocher’s point; a point on the surface of the cranium
2.5 cm from the midline and 1 cm anterior to the cor-
onal suture, approximately 11.5 cm above the nasion).
The target is the ipsilateral frontal horn just anterior to
the foramen of Monro to avoid the choroid plexus. The
right nondominant side is preferred. The catheter is di-
rected freehand, using external landmarks in the coronal
plane towards the ipsilateral medial canthus and in the sa-
gittal plane through the external auditory meatus. A post-
procedural CT scan of the brain is performed within 24
hours as part of standard care for postoperative control,
or earlier in case of postoperative CSF drainage problems.
Mini-tablet application
Regular DICOM viewing software, commonly used in
clinics to evaluate radiological imaging, integrates simple
measurement tools (such as distance or angle measure-
ments). This technique is used to define a trajectory with
an entry point at the frontal paramedian convexity to-
wards the foramen of Monro in a coronal section. Then,
measurements can be taken to determine the angle be-
tween the trajectory and the respective tangent at the
entry point on the skull surface. An iPhone™ (Apple Inc.,
Cupertino, California, United States) software application
is used, importing anonymous imaging material. This
image should be a coronal section with the lateral ventri-
cles shown at the level of the anterior commissure. The
next step is to define a paramedian entry point on the sur-
face of the skull by tapping the finger on the respectivespot. Then, the two feet are virtually placed on the skull
surface. A rectangular trajectory orientation of the tube is
then shown as a dotted line and can be shifted if neces-
sary. The angle deviation from a rectangular insertion is
then given by the software as a value. In addition, the fin-
ger may be placed on the target within the ventricle, and
the length of the catheter will be given as distance value.
As an alternative, the CT scan (at the level: coronal section
with the lateral ventricles shown at the level of the anter-
ior commissure) can be photographed and used for angle
calculations.Outcome assessment
Primary outcome measures
The first primary outcome measure will be the frequency
and percentage of correct placements of the ventricular
catheter, assessed by the three-point scale of Kakarla et al.,
with an additional 1a/1b criteria (Table 1) [21]. The effect
size will be measured using relative risk, absolute risk
reduction, and numbers needed to treat. The second
primary outcome measure will be the frequency and per-
centage of acute ventricular revisions (within one week for
an improperly placed catheter). Assessment is performed
by an investigator blinded to the study allocation. The ef-
fect size will be measured using relative risk, absolute risk
reduction, and numbers needed to treat.Secondary outcome measures
The secondary outcome measures will be the frequency of
placements required, the frequency of completed place-
ments within the ventricle of the perforated part of the
catheter tip, the frequency of very early and early shunt
failures (revision of the ventricular drainage within 24
hours and within the hospital stay), and the frequency and
percentage of complications (procedure-related and non-
surgical) at discharge. The effect size will be measured
using relative risk, absolute risk reduction, and numbers
needed to treat where possible.
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The following parameters will be recorded and used to
demonstrate successful randomization and the presence
of even baseline groups (Table 1):
1. Age (years);
2. Gender (nominal male/female);
3. Glasgow Coma Score on admission (ordinal, 1 to
15-point scale);
4. Cause of hydrocephalus/slit ventricles Preoperative
ventricle size - width (millimeters);
5. Preoperative ventricle size - using the frontal occipital
horn ratio (FOHR; millimeters);
6. Preoperative ventricle size - and the width of the
lateral ventricle in the coronal plane between the
medial wall of the corpus callosum and the septum;
7. Preoperative ventricle size - using the Evans ratio
(bifrontal ventricular span, the ratio of maximum
width of the frontal horns to the maximum width
of the inner table of the cranium; millimeters),
8. Episode of care (nominal, de novo/revision) Time
from symptom onset to admission (hours);
9. Time from symptom onset to randomization
(hours);
10. Time from symptom onset to EVD (external
ventricular drainage placement (hours);
11. Duration of hospital stay (days);
12. Duration of EVD being in place (days);
13. Presence of CSF infection during the first 14 days,
as defined by modified clinical diagnostic criteria for
device-associated meningitis (treatment required on
either positive culture, or elevated cell count, red
cell:white cell ratio, increased lactate, and/or
decreased glucose (nominal, yes/no) [22].
14. The EVD catheter placed for ventriculoperitoneal
shunting (nominal, yes/no).
15. Any associated endoscopic procedure, for example,
third ventriculostomy (freetext);
16. Neurosurgical experience of primary operator
(years).
Consent procedure
Informed consent is obtained from each patient or legal
representative. Patients capable of consenting will be in-
formed about the study details themselves. The detailed
explanation of the study to the patient or legal represen-
tative must be carried out using appropriate explana-
tions and words depending on the previous medical
knowledge of the respective person and his or her level
of education. During the explanations, the respective
person will be asked on a regular basis if they under-
stand the conveyed information and if any questions
have arisen. In addition to these verbal explanations the
patient or legal representative will be given a leafletcontaining the study details. After reading the leaflet the
respective person will be given as much time as they de-
mand for the decision on study participation. This study
evaluates the outcome of an intervention performed
often in an emergency situation. Since approximately
half of patients will not be able to give informed consent
at admission, the informed consent procedure for this
study will be delayed in a so-called emergency proced-
ure. If the patient is capable of giving informed consent
and/or a family representative is available in due time,
an independent neurosurgeon not involved in the patient’s
treatment or in the trial may be asked for study approval.
This option was introduced into the consent procedure
because already available data on smart-phone guided
ventriculostomy suggest a potentially beneficial effect of
the measure for the patient. However, this was performed
in a small group of 35 patients [20]. Therefore it shall not
be categorically withheld from patients who are not cap-
able of deciding whether to participate in the study or not
and who do not have a legal representative. The ethical
vote for this kind of procedure was obtained by the local
ethics committee (approval number: CER 13–175, ap-
proved on 24 March 2014). As soon as a legal representa-
tive is available and/or the patient is capable of consenting
to the study, he or she must be asked to give informed
consent. If the patient or their legal representative refuses
consent after inclusion by the advice of an independent
physician, the patient’s further study participation is no
longer possible. In this case, however, the patient or their
legal representative is asked to give consent for evaluation
of already acquired data.
Sample size analysis
Sample size analysis estimates (hit and miss rates) were
based on the results of observational studies. In a recent
study of our group on the accuracy of ventricular catheter
placement, using anatomic landmarks versus neuronaviga-
tion or XperCT-laser guidance, ventricles were hit in
69.2% of catheter insertions (31% miss rate) using ana-
tomical landmarks (non-assisted), as compared to 82.3%
with the use of guidance (neuronavigation or XperCT-
guidance, P = 0.043) [23]. The placements that were
non-assisted were significantly more likely to be extra-
ventricular than those using guidance (odds ratio: 3.73;
95% confidence interval: 1.24 to 11.19; P = 0.019). Given
data from other retrospective studies on ventricular cathe-
ters (in the context of ventriculoperitoneal shunts), similar
rates of between 25 and 45% [4-7] malpositioning are
described.
To detect a relative risk of 0.5, which is an absolute risk
reduction of 15.5%, 118 patients in each of the two study
arms are needed to gain a power of 80%, using a two-
sided significance level of 95%. The final planned study
size is to include and randomize 236 patients [24].
Sarrafzadeh et al. Trials 2014, 15:478 Page 6 of 9
http://www.trialsjournal.com/content/15/1/478Data management
Data specified in the trial protocol will be documented in
the patient’s digital records. Additional clinical data are
available from the electronic patient files. The investigat-
ing physician is responsible for appropriate completion of
the form. The authors (AS and NS) are responsible for
database development, data acquisition, data storage, and
validation. Data validation includes controls of complete-
ness, consistency, and plausibility of the data documented
in the case report form (CRF) = case report formand elec-
tronic dossier using a query system between data manage-
ment and the investigating physician.
Adverse events and severe adverse events
The term adverse event (AE) describes any sign, symptom,
syndrome, or any disease occurring newly in a trial partici-
pant after consent to the trial and being of particular
interest for the assessment of the disease or the security of
the therapeutic concept. Any AE is documented in the
CRF or electronic file of the patient.
For the purposes of this trial the definition of an ad-
verse event will consist of any one of the following:
1. Impairment of the general condition of the patient,
2. Physical injury, including falls,
3. Infection other than wound infection, sepsis or
Systemic Inflammatory Response Syndrome (SIRS)
Intracranial bleeding in the proximity of the
ventricular catheter,
4. Wound infection or dehiscence at the emersion site
of the ventricular catheter,
5. Newly occurred neurological deficit,
6. Arterial or venous thrombosis,
7. Any suspicious findings that may have relationship
to the study.
For the purposes of this study the definition of a ser-
ious adverse event (SAE) will consist of any one of the
following:
1. Fatal events or death,
2. Any life-threatening condition,
3. Disabling or incapacitating events,
4. Events that require prolongation of hospitalization,
5. Events that require intervention to prevent
permanent impairment.
The relation of the AE or SAE (as a cause or result) to
any other AE or SAE will be scored on a two-point scale;
0 - no, 1 - possible (brief description), or 2 - yes (give
brief description). The investigator’s estimation of the se-
verity of the problem to the study or study device (to be
measured only, if the AE or SAE is or might be related
to study) will be measured and scored on a three-pointscale; 1 - mild, 2 - severe, or 3 – life-threatening. The in-
vestigator’s recommendation to change the protocol, in-
formed consent, or assent form will be given as a binary
answer of yes (with a brief description) or no. The out-
come of AE or SAE will be assessed until discharge using
a four-point scale; 1 - full recovery, 2 - permanent deficit,
3 - not yet fully recovered, or 4 - not known.
Reporting and statistical analysis
The reporting of this trial will conform to the reporting
guidelines outlined in the Consolidated Standards of
Reporting Trials (CONSORT) for non-pharmacological
interventions statement of 2010 [25]. The statistical ana-
lysis will be by the intention-to-treat principle. The occur-
rence of the primary outcome (number and frequency of
correct ventriculostomy) will be compared between the
two randomization groups. The secondary outcome ana-
lyses will compare the above-described variables between
randomization groups. Subgroup analyses will be per-
formed to evaluate whether other parameters such as age,
ventricle size, diagnosis, or experience of the surgeon
may influence the results. Data are presented as mean
and standard deviation or as median with 25/75 percen-
tiles. Stata version 11.2 StataCorp. 2013. Stata Statistical
Software, College Station, Texas, United States) will be
used for all analyses.
Interim analyses
This trial will follow a group sequential design, with two
stop-points (interim and final analysis; K = 2). The trial
will stop if efficacy rules are met. The endpoints assessed
at the first stop-point will be based on primary outcomes
and adverse events. The first will be the interim analysis
which will occur after the accrual of 60 patients in each
arm (120 total), thus representing an information frac-
tion of 0.51 at interim analyses. For the efficacy stop-
point the commonly used O’Brien-Fleming approach will
be used, and a P value of 0.0051 at the interim and
0.0415 at the final analysis will be used [26].
Discussion
Studies assessing catheter malplacement find a high per-
centage of cases of misplacement. Following head trauma,
mass lesions, or in slit ventricles, there is a situation of al-
tered anatomy, rendering catheter placement difficult. For
example, the ventricles may be compressed and deviated
and therefore difficult to cannulate. Furthermore, if the
ventricular catheter is placed in the context of a shunt,
high revision rates add to patient morbidity and proced-
ural costs. As there is a need to improve current practices
in the placement of ventricular catheters, this VENTRI-
GUIDE protocol aims to assess if a portable, easy-to-use,
mini-tablet-assisted guide for ventriculostomy can in-
crease the accuracy of ventriculostomy in comparison
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is the rate of correct placements of the ventricular cath-
eter, measured using a three-point grading scale for the
outcome of each ventriculostomy.
Factors influencing ventricular catheter placement
There are anatomical, technical, and individual patient-
and surgeon-related aspects to consider when placing a
ventricular catheter, in particular, ventricular size and
choroid plexus distance. Preoperative ventricle size is sig-
nificant in its relation to the accuracy of catheter place-
ment [1], which is most relevant in pediatric patients [27].
Larger ventricles are more likely to have optimally placed
catheters, which decreases the risk of proximal obstruc-
tion, and hence increases shunt survival. Interestingly, a
recent study by Wilson et al. in an adult study population
(170 patients, mean age 56 years), which is probably
comparable to our supposed study group, did not show
a correlation of ventricular size by freehand technique
(measured as bifrontal ventricular span or by the Evans
ratio) with risk of inaccurate placement [7]. Also the
distance to the choroid plexus is described as a factor
contributing to catheter occlusion. Ventricular size and
choroid plexus distance are related to the first episode
of shunt failure, particularly in the pediatric population,
because the ventricle size is smaller and the choroid
plexus is larger in the pediatric population [28].
Obstruction, the main cause for shunt failure, may be
due to blockage by the choroid plexus, ventricular debris
or glial tissue growing into its lumen, or due to reduction
in size of the drained ventricle. A retrospective series con-
sidering 90 adult and pediatric patients with 116 shunt
failures identified as main cause for shunt failure proximal
catheter obstruction (38%), followed by infection (29%)
[6]. Mechanical obstruction can be avoided by inserting a
sufficiently long catheter with its tip just anterior to the
foramen of Monro [12]. The length, determined in a pre-
vious study from the CT scan scout film of the patient,
was half of the distance between the external auditory me-
atus and the midpoint of the coronal suture of the skull,
studied in 175 patients, with good results [12]. Also, Wan
et al. identified catheter length as a relevant factor in
avoiding obstruction. In contrast to their expectations
they found, after correcting for age and approach, that a
larger catheter (greater than 8.5 cm) was better placed
than a shorter catheter [1]. Finally, the cause of the
hydrocephalus is related to the survival of the ventricu-
lar catheter, with a higher risk in hemorrhagic ventri-
cles or with ventriculitis. Gender, American Society of
Anesthesiologists (ASA) Physical Status classification
class, emergency, use of prophylactic antibiotic agents,
and duration of surgery were not related to shunt failures
in a pediatric population with 90% use of a ventriculo-
peritoneal shunt [5].Surgical technique
The classical freehand technique uses anatomical land-
marks such as the inner canthus and external auditory
meatus. The catheter is placed in the anterior horn of
the lateral ventricle through a burr hole just anterior to
the coronal suture in the mid-pupillary line (approxi-
mately 11 cm above the nasion and 3 cm from the mid-
line). It is associated with difficulty in gaining optimum
insertion angle and catheter length with better success
rates in experienced surgeons. Optimal trajectories for a
frontal approach were in the mean 42° in the sagittal
plane and 30° in the coronal plane [5].
The surgical technique using the frontal burr hole as
in the present study has the shortest intracerebral route,
with more consistent anatomical landmarks [1]. Others
prefer the parietal approach, as the atrium is usually the
most dilated part of the lateral ventricle [5], proposed
for patients with expected relevant reduction of ven-
tricular size after shunting [29]. The frontal and parietal
burr holes are associated with better placement com-
pared to occipital burr holes [1]. In the present protocol,
a uniform frontal approach has been chosen.
For difficult implantation situations and/or inexperi-
enced neurosurgeons, other techniques have been de-
scribed to reduce the rate of malplacements and related
complications. Frameless neuronavigational stereotaxy [4],
conventional stereotactic, and robotic-image guidance
techniques [30] (n = 17 patients) used for small or slit ven-
tricles have demonstrated accurate placement of ventricu-
lar catheters, however, in relatively small patient groups.
Intracranial neuroendoscopy is another alternative in
selected cases [17]. Also real-time ultrasound-assisted
catheter placement is used in older children, with the
disadvantage of needing a larger burr hole of 1.5 to 2
cm [15]. There are some disadvantages of these sophis-
ticated methods, such as the prolongation of operative
time and dependence on expensive, and sometimes
complicated technologies [18,31]. Nevertheless, the com-
plication rate might be reduced. In a recent study by our
group on the accuracy of ventricular catheter placement
using anatomic landmarks versus neuronavigation or
XperCT-laser guidance, ventricles were hit in 69.2% of
catheter insertions using anatomical landmarks (non-
assisted), as compared to 82.3% with the use of guid-
ance (neuronavigation or XperCT guidance, P = 0.043)
[23]. The placements that were non-assisted were signifi-
cantly more likely to be extraventricular than those using
XperCT (odds ratio: 3.73; 95% confidence interval: 1.24 to
11.19; P = 0.019). Attempts with non-assisted placement
were more likely to result in an unsafe trajectory com-
pared to those using neuronavigation (odds ratio: 3.16;
95% confidence interval: 1.27 to 7.84; P = 0.013). However,
there was no difference in final intraventricular placement
comparing XperCT guidance placement compared to the
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confidence interval: 0.55 to 3.78; P = 0.46).
Limitations
Simply monitoring of patients and tracking within a study
will already improve performance in most cases, and at-
tention to catheter placement will likely have a similar ef-
fect [19]. In addition, this trial is structured to detect a
rather large difference in ventricular misplacements. We
are seeking an approximate 15% change, from 35 to 20%
hit rate, something which may be very difficult to achieve.
A key limitation is the expected to be an imbalance of
surgical skill and/or a learning curve. The surgeons who
use the freehand technique will be more experienced
using the freehand technique than the mini-tablet-assisted
method because they will have performed more proce-
dures using freehand, and we may underestimate the ef-
fect size of the guide-assisted method.
In addition, we feel that a learning curve is present, but
small because of the similarity between the two proce-
dures. Nonetheless, this limitation is common to surgical
randomized controlled trials and will be minimized as best
as possible within the limitations of our resources, mostly
by doing frequent teaching sessions prior to the opening
of the trial. The clinical diagnosis might have an impact
on the rate of misplacements with highest rates for sub-
optimal placements in trauma patients with a midline
shift on a CT scan [21], an effect reducible using
randomization, as in the present study.
In conclusion, we have developed a protocol to evaluate
if an easy-to-use, portable, image-guided system could re-
duce the need for multiple passes and improve the rate of
accurate catheter placement compared to the standard
freehand technique. In contrast with earlier studies, this
study is prospective, controlled, and randomized. Consid-
ering the high revision rates for patients, especially with
small ventricular sizes, the guided technique may lead
to better outcome and may be cost-effective. Since the
outcome of catheter placement is assessed using an estab-
lished grading system for catheter tip location post-
surgery as the primary endpoint, this study will provide an
answer for whether an increase of accuracy for ventri-
culostomy can be reached in patients with guided
ventriculostomy.
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